NOBLEOAK LIFE LIMITED (NOL)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

NOL

NOL - NOBLEOAK LIFE LIMITED

FNArena Sector : Insurance
Year End: June
GICS Industry Group : Insurance
Debt/EBITDA: N/A
Index:

0

LAST PRICE CHANGE +/- CHANGE % VOLUME

$1.24

11 Sep
2026

-0.020

OPEN

$1.27

-1.59%

HIGH

$1.27

18

LOW

$1.24

OTHER COMPANIES IN THE SAME SECTOR
AUB . FCL . GDG . HLI . IAG . MPL . NHF . QBE . SDF . SUN . TWR .
FNARENA'S MARKET CONSENSUS FORECASTS

- No Record -

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202120222023202420252026
EPS Basic xxxxxxxxxxxxxxx15.2
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx527.9 M
Book Value Per Share xxxxxxxxxxxxxxx111.3
Net Operating Cash Flow xxxxxxxxxxxxxxx67.4 M
Net Profit Margin xxxxxxxxxxxxxxx2.67 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202120222023202420252026
Return on Capital Employed xxxxxxxxxxxxxxx14.66 %
Return on Invested Capital xxxxxxxxxxxxxxx14.10 %
Return on Assets xxxxxxxxxxxxxxx2.31 %
Return on Equity xxxxxxxxxxxxxxx14.66 %
Return on Total Capital xxxxxxxxxxxxxxx20.28 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx67.2 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202120222023202420252026
Short-Term Debt xxxxxxxxxxxxxxx0 M
Long Term Debt xxxxxxxxxxxxxxx4 M
Total Debt xxxxxxxxxxxxxxx4 M
Goodwill - Gross xxxxxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxxxxx80 M
Price To Book Value xxxxxxxxxxxxxxx1.07

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202120222023202420252026
Capex xxxxxxxxxxxxxxx0.2 M
Capex % of Sales xxxxxxxxxxxxxxx0.04 %
Cost of Goods Sold xxxxxxxxxxxxxxx-
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx-11 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx324 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

0
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Shaw and Partners

01/09/2026

1

Buy

$3.00

141.94%

Shaw and Partners maintains a Buy rating for NobleOak Life with its target price increased to $3.00 from $2.85 following an FY26 result featuring underlying NPAT of $21.1m and in-force premiums of $549.2m.

The life insurer delivered an 18% increase in in-force premiums and a 15% rise in underlying NPAT, supported by a 12.5% lapse rate outperforming the broader industry.

Management issued FY27 guidance targeting minimum in-force premium growth of 12% alongside underlying NPAT growth of at least 10%.

The analyst notes growth was underpinned by disciplined underwriting, margin stability, and increasing artificial intelligence adoption.

The broker considers the stock to be trading well below its embedded value of $2.34 per share, justifying the retained rating and upgraded valuation.

FORECAST
Shaw and Partners forecasts a full year FY26 dividend of 0.00 cents and EPS of 21.70 cents.
Shaw and Partners forecasts a full year FY27 dividend of 0.00 cents and EPS of 25.00 cents.

NOL STOCK CHART